Navigation Links
Reportlinker Adds The Antibacterials Market Outlook to 2016
Date:5/30/2011

NEW YORK, May 30, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Antibacterials Market Outlook to 2016

http://www.reportlinker.com/p0535949/The-Antibacterials-Market-Outlook-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Introduction

This report provides comprehensive coverage of the global antibacterials market, incorporating disease overview, epidemiological analyses of the major indications, market dynamics. Resistors and drivers are examined along with the most promising areas of growth. Current leading antibacterial brands are assessed and five of the market's leading players are profiled.

Features and benefits

* Assess the forecast epidemiology and development of the antibacterials market across the 7MM.

* Analyze the dynamics of the global antibacterials market and understand the impact of key R&D events, market trends, and issues.

* Gain up-to-date competitive intelligence and understand the major issues affecting key pharmaceutical marketers and product development.

* Predict revenues for major currently marketed and pipeline antibacterial products over 2010–16

* Develop strategies for success in the future antibacterial market.

Highlights

Of the competing drug classes in global antibacterials market, cephalosporins occupied the leading position with over 25% share followed by penicillins and fluoroquinolones. However, all these drug classes declined in sales in 2010.

Despite high patient numbers, the cost and complexities coupled with regulatory uncertainties and challenges have shifted the investment focus of pharmaceutical manufacturers from antibacterials to treatments for chronic conditions.

Community acquired pneumonia (CAP) and hospital acquired pneumonia (HAP) infections are attracting research interest. Additionally, the majority of companies developing new antibiotics are targeting cell wall synthesis inhibitors, DNA topoisomerase II inhibitors, ribosomal inhibitors and methionine tRNA ligase inhibitors.

Your Key questions answered

* What are the drivers and resistors of the antibacterials market worldwide?

* What market and pipeline developments are shaping the strategies of leading pharmaceutical companies in the antibacterials market?

* What is the forecast commercial potential of the most promising compounds in clinical development?

* Who were the leading players in the global antibacterials market in 2010?

* How have recent launches from companies such as GSK, Pfizer, J&J, Novartis and Merck & Co. performed?

Executive Summary

Disease overview and epidemiology

Global market analysis

Pipeline analysis

Competitive landscape

About the author

Disclaimer

Disease overview and epidemiology

Summary

Introduction

Bacterial infections

Diagnosis, treatment and management

Epidemiology of bacterial infections

Forecast epidemiology

Global market analysis

Summary

Introduction

Market dynamics

Leading brands dynamics

Resistors of the antibacterial market

Drivers of the antibacterial market

Global antibacterial market sales forecast

Pipeline analysis

Summary

Introduction

Antibacterial pipeline

Key events in antibacterial R&D

Cubist settles patent infringement litigation with Teva over Cubicin

Merck & Co. intends to strengthen antibacterial research through BioRelix

GSK exercises its option with Anacor to commercialize GSK2251052

Zeftera withdrawn following concerns raised by the FDA and the EMA

Durata Therapeutics initiates Phase III trials for dalbavancin

Leading drugs in development

Profiles of key pipeline products

Pipeline forecast to 2016

Competitive landscape

Summary

Introduction

GlaxoSmithKline

Overview

Financial performance

Marketed product portfolio

Research and development

Strategic and growth analysis

Pfizer

Overview

Financial performance

Marketed product portfolio

Research & development

Strategic and growth analysis

Johnson & Johnson

Overview

Financial performance

Marketed product portfolio

Research & development

Strategic and growth analysis

Merck & Co.

Overview

Financial performance

Marketed product portfolio

Research & development

Strategic and growth analysis

Novartis

Overview

Financial performance

Marketed product portfolio

Research & development

Strategic and growth analysis

Appendix

Scope

Market size methodology

Epidemiology

Market forecast

Abbreviations

To order this report:

Drug and Medication Industry: The Antibacterials Market Outlook to 2016

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
2. Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016
3. Reportlinker Adds The Infusion Pump Market Outlook to 2016
4. Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook
5. Reportlinker Adds Advances in Drug-Diagnostic Co-Development
6. Reportlinker Adds Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management
7. Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
8. Reportlinker Adds Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
9. Reportlinker Adds Global: Pharmaceuticals Industry Guide
10. Reportlinker Adds Saxagliptin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
11. Reportlinker Adds Generic Pharmaceuticals Industry - Top 200 Generic Pharmaceuticals Industry (Global)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global fluoropolymer market in the healthcare industry to grow ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/17/2017)... Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, today announced ... pharmaceutical development at Tocagen, will present at Phacilitate Cell & ... Miami . Details of the ... ... - what to do when and why Date and Time: Wednesday, ...
(Date:1/17/2017)... 2017 Research and Markets has announced the ... Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug ... 2021" report to their offering. ... The global active pharmaceutical ingredients market is ... Billion in 2016, growing at a CAGR of 6.3% from 2016 ...
Breaking Medicine Technology:
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Gym Source, ... of a new showroom at South Dixie Hwy in Miami, FL. , “We are ... Gym Source. “The new innovative in-store concept is designed to give clients a seamless ...
(Date:1/17/2017)... Los Angeles, CA (PRWEB) , ... January 17, ... ... conflicted and concerned by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting ... tragedies and magical moments that help everyone endure and pass through tough times, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Kevin Harrington (one of the original Sharks ... DRTV campaigns regarding the topic of Beauty and Personal Care. , ... What better way to commit to these changes than beginning with personal care and ...
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve TMS West, with multiple ... new office in San Clemente, California this month. Achieve TMS West is the ... treating individuals struggling with major depression. Depression impacts over 15 million adults in ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is pleased to ... on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more ... addition to our provider network, and the addition will benefit our members in ...
Breaking Medicine News(10 mins):